{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:04Z","timestamp":1791446764545,"version":"4.3.3"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,12,22]]},"DOI":"10.1001\/jama.2020.23138","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T11:46:29Z","timestamp":1608637589000},"page":"2497","source":"Crossref","is-referenced-by-count":220,"title":["Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life"],"prefix":"10.1001","volume":"324","author":[{"given":"Dipak","family":"Kotecha","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, England"},{"name":"Centre for Patient Reported Outcomes Research, University of Birmingham, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina V.","family":"Bunting","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrat K.","family":"Gill","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mehta","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Stanbury","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement Team, RATE-AF Trial, West Midlands, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C.","family":"Jones","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement Team, RATE-AF Trial, West Midlands, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Haynes","sequence":"additional","affiliation":[{"name":"Patient and Public Involvement Team, RATE-AF Trial, West Midlands, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Calvert","sequence":"additional","affiliation":[{"name":"Centre for Patient Reported Outcomes Research, University of Birmingham, Birmingham, England"},{"name":"NIHR Biomedical Research Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, England"},{"name":"Birmingham Health Partners Centre for Regulatory Science and Innovation, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Deeks","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, England"},{"name":"NIHR Biomedical Research Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Steeds","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Y.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Medical Sciences Division, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Rahimi","sequence":"additional","affiliation":[{"name":"Deep Medicine, Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford, Oxford, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Camm","sequence":"additional","affiliation":[{"name":"Cardiology Clinical Academic Group Molecular and Clinical Sciences Institute, St George's University of London, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Griffith","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, England"},{"name":"Thrombosis Research Unit, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Townend","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Hospitals Birmingham NHS Foundation Trust, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, England"},{"name":"University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"joi200126r1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005155","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care.","volume":"6","author":"Lane","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"joi200126r2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice.","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"joi200126r3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015099","article-title":"A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.","volume":"7","author":"Kotecha","year":"2017","journal-title":"BMJ Open"},{"issue":"46","key":"joi200126r4","first-page":"3250","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"issue":"20","key":"joi200126r5","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.jacc.2016.08.048","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins.","volume":"68","author":"Kotecha","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"joi200126r6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction.","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"issue":"9961","key":"joi200126r7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u00df blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"issue":"38","key":"joi200126r8","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"joi200126r9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12916-020-01564-3","article-title":"Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment.","volume":"18","author":"Ziff","year":"2020","journal-title":"BMC Med"},{"key":"joi200126r10","doi-asserted-by":"publisher","first-page":"i1855","DOI":"10.1136\/bmj.i1855","article-title":"Effect of age and sex on efficacy and tolerability of \u00df blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"joi200126r11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure.","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"joi200126r12","doi-asserted-by":"publisher","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"joi200126r13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tcm.2016.03.011","article-title":"Digoxin: the good and the bad.","volume":"26","author":"Ziff","year":"2016","journal-title":"Trends Cardiovasc Med"},{"issue":"23","key":"joi200126r14","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.jacc.2019.09.059","article-title":"Impact of renal impairment on beta-blocker efficacy in patients with heart failure.","volume":"74","author":"Kotecha","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"joi200126r15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/europace\/eux299","article-title":"European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers.","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"issue":"11","key":"joi200126r16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165790","article-title":"Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties.","volume":"11","author":"Kotecha","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"joi200126r18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.echo.2019.08.015","article-title":"A practical guide to assess the reproducibility of echocardiographic measurements.","volume":"32","author":"Bunting","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"joi200126r19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"1","key":"joi200126r20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12955-020-01344-w","article-title":"How is the minimal clinically important difference established in health-related quality of life instruments? review of anchors and methods.","volume":"18","author":"Mouelhi","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"joi200126r21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1183\/09031936.00194909","article-title":"The 6-min walk distance in healthy subjects: reference standards from seven countries.","volume":"37","author":"Casanova","year":"2011","journal-title":"Eur Respir J"},{"issue":"5","key":"joi200126r22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/hrt.2006.107573","article-title":"A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland.","volume":"93","author":"Murphy","year":"2007","journal-title":"Heart"},{"issue":"10","key":"joi200126r23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1159\/000511048","article-title":"Importance and assessment of quality of life in symptomatic permanent atrial fibrillation: patient focus groups from the RATE-AF trial.","volume":"145","author":"Jones","year":"2020","journal-title":"Cardiology"},{"issue":"24","key":"joi200126r25","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","article-title":"Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure.","volume":"69","author":"Kotecha","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"joi200126r26","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation.","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"joi200126r27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12955-015-0237-1","article-title":"Assessment of health-related quality of life using the SF-36 in Chinese cervical spondylotic myelopathy patients after surgery and its consistency with neurological function assessment: a cohort study.","volume":"13","author":"Zhang","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"joi200126r28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0062","article-title":"Association of the 36-Item Short Form Health Survey physical component summary score with patient satisfaction and improvement 2 years after total knee arthroplasty.","volume":"2","author":"Teo","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"12","key":"joi200126r29","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/acr.v66.12","article-title":"Clinically important changes in Short Form 36 Health Survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness.","volume":"66","author":"Ward","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"joi200126r30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12931-019-1010-5","article-title":"Psychometric properties and minimal important differences of SF-36 in idiopathic pulmonary fibrosis.","volume":"20","author":"Witt","year":"2019","journal-title":"Respir Res"},{"key":"joi200126r31","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/j.wneu.2019.02.060","article-title":"Predictors of health-related quality of life for mental health status in patients after carotid endarterectomy.","volume":"126","author":"Jiang","year":"2019","journal-title":"World Neurosurg"},{"issue":"2","key":"joi200126r32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","article-title":"A point of minimal important difference (MID): a critique of terminology and methods.","volume":"11","author":"King","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"joi200126r33","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial.","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"joi200126r34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/europace\/eux027","article-title":"Is echocardiography valid and reproducible in patients with atrial fibrillation? a systematic review.","volume":"19","author":"Kotecha","year":"2017","journal-title":"Europace"},{"issue":"3","key":"joi200126r35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/europace\/eux318","article-title":"Integrating new approaches to atrial fibrillation management: the 6th AFNET\/EHRA Consensus Conference.","volume":"20","author":"Kotecha","year":"2018","journal-title":"Europace"},{"key":"joi200126r17","volume-title":"Measuring and Improving Health Outcomes: An SF-36 Primer for the Medicare Health Outcomes Survey.","author":"Ware","year":"2004"},{"key":"joi200126r24","volume-title":"An Account of the Foxglove and Some of Its Medical Uses: Practical Remarks on Dropsy and Other Diseases","author":"Withering","year":"1785"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2774407\/jama_kotecha_2020_oi_200126_1607962892.52158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T11:46:32Z","timestamp":1608637592000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2774407"}},"subtitle":["The RATE-AF Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":35,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12,22]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.23138","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739250270.793583226","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,22]]}}}